7. KAYNAKLAR
1. Lok A, McMahon BJ. Chronic Hepatitis B: Update 2009 AASLD practice guidelines update. Hepatology 2009, September, 50 (3): 1-36
2. Chotiyaputta W, Değertekin B, McKenna BJ ve ark. Characteristics of chronic hepatitis B patients who underwent liver biopsies. Journal of Viral Hepatitis, 2010, August, 17(8) (online)
3. Lozano M, Cid J, Bedini JL ve ark. Study of serum alanine aminotranferase levels in blood donors in Spain. Haematologica 1998; 83:237-239
4. Pratti D, Taioli E, Zanella A ve ark. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002;137: 1-10
5. Kariv R, Leshno M, Beth-Or A ve ark. Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a largescale population study. Liver Int. 2006 May;26(4):445-450
6. Mohamednejad M, Pourshams A,Malekzadeh R ve ark. Healthy ranges of serum alanine aminotranferase levels in Iranian blood donors. World J Gastroenterol 2003;9(10):2322-2324
7. Jamali R, Pourshams A, Amini S ve ark. The upper normal limit of serum alanine aminotranferase in Golestan Province, Northeast Iran. Arch Iranian Med 2008; 11 (6): 602-607
8. Kim HC, Choi KS, Jang YH ve ark. Normal serum aminotranferase levels and the metabolic syndrome : Korean national health and nutrition examination surveys. Yonsei Med J 2006; 47(4): 542-550
37



48. SAYFAYA BENZER SAYFALAR

Normal ve yüksek aminotransferaz düzeyli kronik hepatit c hastalarının demografik, histopatolojik ve biyokimyasal parametreler açısından karşılaştırılması (normal alanin aminotransferaz aralığı kaç olmalıdır?) - Sayfa 62
KAYNAKLAR 1. Hughes CA, Shafran SD. Chronic hepatitis C virus management: 20002005 update. Ann Pharmacother 2006; 40: 74-82 2. Liu C. Hepatitis C virus: virology and experimental systems. Clin Liver Dis 2006; 10: 773-791 3. Franco S, Parera M, Aparicio E, Clotet B, Martinez MA. Genetic and catalytic efficiency structure of an HCV protease quasispecies. Hepatology 2007; 45: 899-910 4. Sievert W...

48. SAYFADAKI ANAHTAR KELIMELER

levels
hepatitis
alanine
chronic
ıntern
liver


48. SAYFA ICERIGI

7. KAYNAKLAR
1. Lok A, McMahon BJ. Chronic Hepatitis B: Update 2009 AASLD practice guidelines update. Hepatology 2009, September, 50 (3): 1-36
2. Chotiyaputta W, Değertekin B, McKenna BJ ve ark. Characteristics of chronic hepatitis B patients who underwent liver biopsies. Journal of Viral Hepatitis, 2010, August, 17(8) (online)
3. Lozano M, Cid J, Bedini JL ve ark. Study of serum alanine aminotranferase levels in blood donors in Spain. Haematologica 1998; 83:237-239
4. Pratti D, Taioli E, Zanella A ve ark. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002;137: 1-10
5. Kariv R, Leshno M, Beth-Or A ve ark. Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a largescale population study. Liver Int. 2006 May;26(4):445-450
6. Mohamednejad M, Pourshams A,Malekzadeh R ve ark. Healthy ranges of serum alanine aminotranferase levels in Iranian blood donors. World J Gastroenterol 2003;9(10):2322-2324
7. Jamali R, Pourshams A, Amini S ve ark. The upper normal limit of serum alanine aminotranferase in Golestan Province, Northeast Iran. Arch Iranian Med 2008; 11 (6): 602-607
8. Kim HC, Choi KS, Jang YH ve ark. Normal serum aminotranferase levels and the metabolic syndrome : Korean national health and nutrition examination surveys. Yonsei Med J 2006; 47(4): 542-550
37

İlgili Kaynaklar







single.php